ÂÜŔňÂŇÂ×

Lauren Silvernail possesses extensive experience in leadership roles within the biotechnology and pharmaceutical sectors. Currently serving as a Member of the Board of Directors for Harrow, Harpoon Therapeutics, and Nicox—where additional leadership includes Chair positions on various committees—Lauren also has held executive roles as Chief Financial Officer and Executive Vice President of Corporate Development at Evolus, and as Chief Business Officer and Chief Financial Officer at Revance Therapeutics. Educational qualifications include an MBA in Finance from UCLA Anderson School of Management and a BA in Biophysics from the University of California, Berkeley.